Eaton Vance Management Has $95,522,000 Position in UnitedHealth Group Incorporated (UNH)

Eaton Vance Management increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% during the third quarter, Holdings Channel reports. The firm owned 682,302 shares of the healthcare conglomerate’s stock after buying an additional 14,413 shares during the period. Eaton Vance Management owned 0.07% of UnitedHealth Group worth $95,522,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of UNH. Capital World Investors raised its stake in UnitedHealth Group by 1.0% in the third quarter. Capital World Investors now owns 41,616,604 shares of the healthcare conglomerate’s stock worth $5,826,325,000 after buying an additional 401,303 shares during the period. BlackRock Institutional Trust Company N.A. raised its stake in UnitedHealth Group by 2.3% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 26,506,549 shares of the healthcare conglomerate’s stock worth $3,710,917,000 after buying an additional 600,139 shares during the period. BlackRock Fund Advisors raised its stake in UnitedHealth Group by 1.7% in the third quarter. BlackRock Fund Advisors now owns 14,442,889 shares of the healthcare conglomerate’s stock worth $2,022,004,000 after buying an additional 245,967 shares during the period. Northern Trust Corp raised its stake in UnitedHealth Group by 0.9% in the third quarter. Northern Trust Corp now owns 11,511,275 shares of the healthcare conglomerate’s stock worth $1,611,578,000 after buying an additional 97,070 shares during the period. Finally, Bank of New York Mellon Corp raised its stake in UnitedHealth Group by 2.9% in the third quarter. Bank of New York Mellon Corp now owns 11,150,584 shares of the healthcare conglomerate’s stock worth $1,561,082,000 after buying an additional 317,180 shares during the period. Institutional investors and hedge funds own 86.54% of the company’s stock.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNH) traded up 0.19% during trading on Friday, hitting $160.75. The company had a trading volume of 1,905,884 shares. The company’s 50 day moving average price is $161.21 and its 200-day moving average price is $148.35. The company has a market cap of $152.90 billion, a PE ratio of 22.17 and a beta of 0.68. UnitedHealth Group Incorporated has a 12 month low of $112.53 and a 12 month high of $164.00.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, January 17th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts’ consensus estimates of $2.07 by $0.04. UnitedHealth Group had a net margin of 3.92% and a return on equity of 21.20%. The firm earned $47.50 billion during the quarter, compared to analysts’ expectations of $47.12 billion. During the same period in the prior year, the company earned $1.40 EPS. The firm’s revenue was up 9.0% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post $9.51 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 21st. Investors of record on Friday, March 10th will be given a dividend of $0.625 per share. The ex-dividend date of this dividend is Wednesday, March 8th. This represents a $2.50 dividend on an annualized basis and a yield of 1.56%. UnitedHealth Group’s dividend payout ratio (DPR) is 33.47%.

WARNING: This piece of content was reported by sleekmoney and is the property of of sleekmoney. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of US & international copyright and trademark law. The original version of this piece of content can be viewed at http://sleekmoney.com/eaton-vance-management-has-95522000-position-in-unitedhealth-group-incorporated-unh/1657011.html.

Several research analysts recently weighed in on the company. Argus reiterated a “buy” rating and issued a $170.00 price objective on shares of UnitedHealth Group in a research report on Monday, January 23rd. Jefferies Group LLC reiterated a “buy” rating and issued a $186.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 16th. Oppenheimer Holdings, Inc. increased their price objective on UnitedHealth Group from $161.00 to $171.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 30th. Barclays PLC reiterated a “buy” rating and issued a $187.00 price objective on shares of UnitedHealth Group in a research report on Monday, January 9th. Finally, Leerink Swann increased their price objective on UnitedHealth Group from $185.00 to $195.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 30th. One equities research analyst has rated the stock with a hold rating and twenty-two have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $175.41.

In other UnitedHealth Group news, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction on Thursday, December 15th. The shares were sold at an average price of $159.80, for a total value of $2,397,000.00. Following the transaction, the director now owns 1,940,030 shares in the company, valued at approximately $310,016,794. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gail R. Wilensky sold 5,460 shares of the business’s stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $150.55, for a total transaction of $822,003.00. Following the completion of the transaction, the director now owns 60,052 shares in the company, valued at approximately $9,040,828.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 75,460 shares of company stock valued at $11,975,503. 1.65% of the stock is owned by corporate insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/eaton-vance-management-has-95522000-position-in-unitedhealth-group-incorporated-unh/1657011.html

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *